INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Saffron extract and memantine produced similar cognitive outcomes in moderate to severe Alzheimer's.

In a 12-month double-blind trial, 68 patients with moderate to severe Alzheimer's disease received either 30 mg daily of saffron extract or 20 mg daily of memantine. Changes on the Severe Cognitive Impairment Rating Scale (P = 0.38) and Functional Assessment Staging (P = 0.87) did not differ significantly between treatments. Adverse event rates were also comparable between the two interventions.

Study type
Randomized controlled trial
Who was studied
68 patients with moderate to severe Alzheimer's disease
What was measured
Severe Cognitive Impairment Rating Scale and Functional Assessment Staging scores

THE PAPER

Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial.

Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, Farsad F, Kamalipour M, Akhondzadeh S. Hum Psychopharmacol, 2014.

PubMed 25163440 ↗DOI 10.1002/hup.2412 ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.